Literature DB >> 6886409

The importance of antineuraminidase antibodies in resistance to influenza A and immunologic memory for their synthesis.

A N Naikhin, I M Tsaritsina, E V Oleinikova, L G Syrodoeva, N L Korchanova, G M Denisov.   

Abstract

Eight hundred and seventy-seven sera from 360 adults aged 18-50 who were under permanent observation from October 1980 to March 1981 have been studied by haemagglutination-inhibition (HI) and erythrocyte elution-inhibition (EI) tests--a simplified method of antineuraminidase antibody titration. It was demonstrated in some subjects infected with influenza A H1N1 and H3N2 viruses that the antibody rise was to one of the surface antigens only--haemagglutinin or neuraminidase. These subjects made up 5.2-25.8% of all examinees. The protective effect of antibodies to neuraminidase was similar to that of antihaemagglutinins. Interaction of both types of antibodies was observed in protection against the disease. Data have been obtained on the influence of antineuraminidase antibodies in decreasing the severity of natural infection with influenza A. A study of heterologous immunologic responses to haemagglutinin and neuraminidase among persons immunized with live influenza A H1N1 and H3N2 vaccines and among children naturally infected with influenza A H3N2 demonstrated the presence of immunologic memory for antineuraminidase antibody synthesis. Thus, the suggestion of a common antigenic structure for neuraminidase N1 and N2 is made.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6886409      PMCID: PMC2129297          DOI: 10.1017/s0022172400060101

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  10 in total

1.  A serological recapitulation of human infection with different strains of influenza virus.

Authors:  T FRANCIS; F M DAVENPORT; A V HENNESSY
Journal:  Trans Assoc Am Physicians       Date:  1953

2.  The assay of influenza antineuraminidase activity by an elution inhibition technique.

Authors:  G Appleyard; J D Oram
Journal:  J Gen Virol       Date:  1977-01       Impact factor: 3.891

Review 3.  Determinants of immunity to influenza infection in man.

Authors:  C W Potter; J S Oxford
Journal:  Br Med Bull       Date:  1979-01       Impact factor: 4.291

4.  [Antigenic and immunogenic activity of influenza virus virion components].

Authors:  N I Milovidova; L A Porubel'; V P Ginzburg; Iu Z Gendon
Journal:  Vopr Virusol       Date:  1974 Nov-Dec

5.  Effect of neuraminidase antibody on Hong Kong influenza.

Authors:  A S Monto; A P Kendal
Journal:  Lancet       Date:  1973-03-24       Impact factor: 79.321

6.  The significance of influenza virus neuraminidase in immunity.

Authors:  R Rott; H Becht; M Orlich
Journal:  J Gen Virol       Date:  1974-01       Impact factor: 3.891

7.  Association of serum anti-neuraminidase antibody with resistance to influenza in man.

Authors:  B R Murphy; J A Kasel; R M Chanock
Journal:  N Engl J Med       Date:  1972-06-22       Impact factor: 91.245

8.  [Role of antineuraminidase antibodies in the human immunological response to the administration of live type A influenza vaccines].

Authors:  A N Naĭkhin; N V Topuriia; G M Denisov
Journal:  Mikrobiol Zh       Date:  1980 Sep-Oct

9.  Effect of specific immunity to viral neuraminidase on subsequent influenza virus infection in man.

Authors:  N Yamane; T Odagiri; J Arikawa; M Kumasaka; N Ishida
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

10.  Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

Authors:  J L Schulman; M Khakpour; E D Kilbourne
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

  10 in total
  3 in total

Review 1.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

2.  Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross-reactivity without antigenic competition.

Authors:  B E Johansson; E D Kilbourne
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 3.  Overview of Serological Techniques for Influenza Vaccine Evaluation: Past, Present and Future.

Authors:  Claudia Maria Trombetta; Daniele Perini; Stuart Mather; Nigel Temperton; Emanuele Montomoli
Journal:  Vaccines (Basel)       Date:  2014-10-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.